Results for Next Generation DNA/RNA Sequencing

1 - 6 of 6

Dr. Diskin's research is focused on translational genomics in childhood cancers. Her laboratory seeks to identify the genetic basis of childhood cancers by combining quantitative computational methods with rigorous "wet-lab" experimental approaches. In parallel, she has developed, and is applying, a proteogenomic approach to identify novel immunotherapeutic targets for high-risk and relapsed pediatric malignancies.

E-mail:

diskin [at] chop.edu

In the News: Aplastic Anemia, Boricua Mutation, Oligodendroglioma, cWGS Infants

Published on

Oct 1, 2021

in Cornerstone Blog

This week’s roundup features new partnerships, novel findings, and exciting approaches to diagnosing rare conditions.

Minority-Enriched Genomics Leading to More Precise Healthcare of the Future

Published on

Jul 27, 2020

in Cornerstone Blog

Center for Applied Genomics receives NIH funding to study the risk of disease in African Americans by combining genomic and environmental factors.

High Throughput Sequencing Core Services

View a list of High Throughput Sequencing Core's services.

Diskin Laboratory

Translational genomics in childhood cancers is the central focus of the Diskin Lab, which works to identify the inherited and acquired genetic drivers of cancer by combining quantitative computational methods with rigorous experimental approaches in the lab.

The Myelin Disorders Biorepository Project (MDBP)

This study involves the collection of medical information and samples from people with a confirmed or suspected leukodystrophy or related disorder affecting the white matter of the brain, as well as "healthy controls" who are not known to be affected by one of these disorders.